GAD2 and nervous system disorder: Though cognitive findings specific to SPS phenotype were not reported separately, they found that 18% (n = 38) of their cohort with various anti-GAD65 associated neurological disorders had cognitive impairment as diagnosed by the Kokmen short test of mental status (11, 27).